Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 07/29/16

    • 30-Day SEC Yield1

      1.66%
    • Total Net Assets

      $268.2M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2016
  • Portfolio Composition (%)
    as of 07/29/16

    • % of Net Assets
    • Stocks

      100.27
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.27
  • Download All HoldingsDaily Holdings (%) as of 07/29/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    111,480
    13,960,6405.20
    Abbvie Inc
    ABBV US
    209,123
    13,850,2165.16
    Glaxosmithkline Plc
    GSK US
    303,672
    13,686,4975.10
    Pfizer Inc
    PFE US
    366,216
    13,509,7085.04
    Astrazeneca Plc
    AZN US
    391,976
    13,382,0614.99
    Abbott Laboratories
    ABT US
    298,591
    13,361,9474.98
    Sanofi
    SNY US
    311,815
    13,292,6734.96
    Novartis Ag
    NVS US
    158,610
    13,205,8694.92
    Bristol-Myers Squibb Co
    BMY US
    175,852
    13,155,4884.90
    Merck & Co Inc
    MRK US
    224,040
    13,142,1864.90
    Allergan Plc
    AGN US
    51,646
    13,063,8564.87
    Novo Nordisk A/S
    NVO US
    225,764
    12,861,7754.80
    Eli Lilly & Co
    LLY US
    155,095
    12,855,8254.79
    Zoetis Inc
    ZTS US
    239,798
    12,102,6054.51
    Mckesson Corp
    MCK US
    61,884
    12,040,1514.49
    Shire Plc
    SHPG US
    61,596
    11,957,0164.46
    Mylan Nv
    MYL US
    249,798
    11,688,0484.36
    Teva Pharmaceutical Industries Ltd
    TEVA US
    215,192
    11,512,7724.29
    Amerisourcebergen Corp
    ABC US
    125,589
    10,698,9273.99
    Perrigo Co Plc
    PRGO US
    99,759
    9,116,9753.40
    Valeant Pharmaceuticals International I
    VRX US
    208,015
    4,638,7351.73
    Jazz Pharmaceuticals Plc
    JAZZ US
    27,263
    4,115,8951.53
    Mallinckrodt Plc
    MNK US
    52,856
    3,559,3231.33
    Akorn Inc
    AKRX US
    64,593
    2,211,0180.82
    Endo International Plc
    ENDP US
    113,129
    1,963,9190.73
    Other/Cash
    --
    --
    -711,805-0.27
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.